Clene Inc. is a leading biotechnology company focused on developing innovative nanotechnology-based solutions for neurodegenerative diseases. With a focus on precision medicine, Clene is pioneering the use of nanocatalysis to enhance cellular bioenergetics and promote neuroprotection. Their groundbreaking research has the potential to revolutionize the treatment of conditions like multiple sclerosis and Parkinson’s disease.
Notification